27
Bempedoic acid lowers LDL cholesterol levels in the body. Its effect is based on a reduction in cholesterol synthesis and an increase in LDL receptors in the liver. The agent also reduces the synthesis of fatty acids.
The cholesterol reducer will be registered in the Netherlands in 2022 for the treatment of adults with primary hypercholesterolemia or mixed…
The entire content of this article is only accessible to subscribers.
Read 3 articles FREE
Make an account. Free and without obligation.
I want 3x free
Always access to all NTvG publications?
Subscribe today!
Take the introductory subscription
€ 31.95 for 12 weeks!
I want to meet
Do you already have a subscription? login